DowDuPont Inc. today raised its forecast for cost savings from its push to divide itself into three companies and updated its timeline to complete the process. It produces agricultural chemicals, material science, and specialty chemical products.
DowDuPont met regulatory remedies required of the merger transaction, including: divesting DuPont's cereal broadleaf herbicides and chewing insecticides portfolios, as well as certain parts of its crop protection R&D pipeline and organization to FMC.
Several other analysts also recently weighed in on DWDP. Credit Suisse Group reissued an "outperform" rating and set a $79.00 price target (up previously from $73.00) on shares of DowDuPont in a research report on Thursday, October 12th. Jefferies Group restated a buy rating and issued a $80.00 price objective on shares of DowDuPont in a report on Sunday, October 8th. The rating was upgraded by Barclays Capital to "Equal-Weight" on Wednesday, January 31.
Adjusted earnings per share for the fourth quarter increased 41 percent to $0.83 a share compared with pro forma adjusted earnings per share in the year-ago period of $0.59. They set an overweight rating and a $83.00 price target on the stock. Finally, UBS Group boosted their price target on shares of DowDuPont from $82.00 to $85.00 and gave the stock a buy rating in a research note on Friday, November 3rd. $81.17's average target is 14.50% above currents $70.89 stock price. The company expects this new legislation to translate into a 1-2 percentage point reduction in its 2018 tax rate versus previous expectations. DowDuPont has a one year low of $64.01 and a one year high of $77.08. The company has market cap of $165.88 billion.
(DWDP) on Thursday reported a loss of $1.26 billion in its fourth quarter. DowDuPont had a return on equity of 9.73% and a net margin of 5.01%.
Revenue climbed 13 percent to $20.1 billion, compared with the $19.5 billion analysts expected.
In other news, General Counsel Charles J. Kalil sold 78,895 shares of the company's stock in a transaction dated Tuesday, November 7th. The shares were sold at an average price of $72.23, for a total transaction of $13,536,046.46. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The stock was sold at an average price of $71.01, for a total value of $476,335.08. The disclosure for this sale can be found here.
The stock decreased 3.55% or $2.61 during the last trading session, reaching $70.89.
Large investors have recently bought and sold shares of the stock. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/02/favorable-news-coverage-somewhat-unlikely-to-affect-dowdupont-dwdp-share-price.html. AllSquare Wealth Management LLC acquired a new stake in shares of DowDuPont in the third quarter valued at about $108,000. Synovus Financial Corp bought a new stake in DowDuPont during the third quarter worth about $9,887,000. (NYSE:DWDP) rating on Friday, October 27. If you are reading this article on another website, it was stolen and republished in violation of US and worldwide copyright & trademark law. The rating was maintained by SunTrust on Thursday, February 1 with "Hold".
Since DowDuPont has so many businesses, it was able capture growth in demand for semiconductors, nutritional ingredients, construction chemicals, and automotive materials. I. du Pont de Nemours and Company (DuPont).
The materials-science business will go it alone by the end of March 2019, with the agriculture and specialty products following about two months later, Breen said. This division also offers biotech traits, seed-applied technologies, and digital agriculture products.